|4Jan 5, 8:33 PM ET

Hexter Joshua 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 5, 2022

Insider Transaction Report

Form 4
Period: 2022-01-03
Hexter Joshua
COO & CBO
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-03+36,00036,000 total
    Exercise: $13.89Exp: 2032-01-03Common Stock (36,000 underlying)
  • Award

    Common Stock

    2022-01-03+21,000124,333 total
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 5,250 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
  • [F2]The Stock Option will vest in 4 installments as follows: 9,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Documents

1 file
  • 4
    ownership.xmlPrimary